Human immunogenicity studies on group A streptococcal C5a peptidase (SCPA) as a potential vaccine against group A streptococcal infections.

Source:http://linkedlifedata.com/resource/pubmed/id/15232171

Download in:

View as

General Info

PMID
15232171